[2YIA18m] YIA Pharmacology Group 2

[2YIA18m-8] HMG-CoA reductase inhibitors alleviate different types of chemotherapy induced-peripheral neuropathy via activation of GST

^○Fuka Aizawa^1,2, Ami Okabayashi², Takahiro Niimura^2,3, Karin Takeuchi², Kenta Yagi^2,3, Yoshito Zamami⁴, Mitsuhiro Goda^1,2, Kei Kawada^2,5, Yuki Izawa-Ishizawa^2,6, Keisuke Ishizawa^1,2,3 (1.Dept. Pharm., Tokushima Univ. Hosp., 2.Dept. Clin. Pharmacol. & Therap., Grad. Sch. of Biomed. Sci., Tokushima Univ., 3.Clin. Res. Ctr. Dev. Therap., Tokushima Univ. Hosp., 4.Dept. Pharm., Okayama Univ. Hosp., 5.Dept. Pharm. Pract. Pedagog., Tokushima Univ., 6.Dept. Gen. Med., Taoka Hosp.)

Login required to view

Login is required to view some content.

Log in